Annual Congress Vienna 2009

Saturday, 12.09.2009
Sunday, 13.09.2009
Monday, 14.09.2009
Tuesday, 15.09.2009
Wednesday, 16.09.2009

Citations should be made in the following way: Authors. Title. Eur Respir J 2009; 34: Suppl. 53, abstract number.


Material from 2009:
  • 4047 Abstracts
  • 652 Slide presentations
  • 300 Webcasts
  • 93 Handouts
  • 2150 e-posters
  • 300 Multimedia files
Material from 2009:  Show

New drugs for airways disease

Oral Presentation
Chairs: G. Joos (Gent, Belgium), C. Gratziou (Athens, Greece)
A phase 1 multiple dose safety and pharmacokinetics study of AIR645, an inhaled IL-4rα 2-MOE GAPMER oligonucleotide
M. Hodges, E. Castelloe, A. Chen, R. Geary, J. Karras, R. Larouche, D. Shapiro, B. Yeung, R. Yu, S. Gregory (San Diego, Carslbad, United States Of America; Montréal, Canada)
Congress or journal article abstract
Congress or journal article abstract
Tolerability and efficacy of inhaled AZD4818, a CCR1 antagonist, in moderate to severe COPD patients
H. Kerstjens, L. Bjermer, J. Vestbo, L. Eriksson, K. Dahlstrom (Groningen, Netherlands; Lund, Sweden; Hvidovre, Denmark)
Congress or journal article abstract
Congress or journal article abstract
Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients
S. Snape, C. Fox, N. Snell, M. Fizgerald, N. Barnes, I. Pavord, P. Jeffery, A. Antczak, E. Nizankowska-Mogilnicka (Harlow, United Kingdom)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
Safety and efficacy of an inhaled epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (BIBW 2948) in COPD
P. Woodruff, J. Hohlfeld, N. Krug, M. Dransfeld, R. Sutherland, G. Criner, V. Kim, A. Prasse, C. Nivens, K. Tetzlaff, J. Fahy (San Francisco, Birmingham, Denver, Philadelphia, Ridgefield, United States Of America; Hannover, Freiburg, Germany)
Congress or journal article abstract
Congress or journal article abstract
Fluticasone furoate, a novel inhaled corticosteroid (ICS), provides sustained protection against amp airway hyperresponsiveness (AHR) in mild asthma
M. van den Berge, B. Luijk, P. Bareille, V. M. Roussel, D. S. Postma, J. W. J. Lammers (Groningen, Utrecht, Netherlands; Greenford, United Kingdom)
Congress or journal article abstract
Congress or journal article abstract
Anti-inflammatory activity of low molecular weight heparin in patients with exacerbations of COPD
B. Rybacka-Chabros, J. Niedzwiadek (Lublin, Poland)
Congress or journal article abstractSlide presentation
Congress or journal article abstractSlide presentation
The dynamics of oxidative stress markers in patients with asthma exacerbation during the course of liposome admission
A. V. Lisitsa, I. A. Klimanov, S. K. Soodaeva (Moscow, Russian Federation)
Congress or journal article abstractSlide presentationE-poster
Congress or journal article abstractSlide presentationE-poster
Inhaled solid lipid nanoparticles as a new tool for drug delivery in the lung
G. Miserocchi, I. Rivolta, D. Salerno, A. Panariti, P. Gasco (Monza, Torino, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster